Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1976 Jul;52(609):445–451. doi: 10.1136/pgmj.52.609.445

Glucose intolerance, diabetes mellitus and atherosclerosis; prospects for prevention

Harry Keen
PMCID: PMC2496394  PMID: 967763

Abstract

Increased prevalence and incidence of arterial disease has become the major cause of disability and death in diabetics in Western cultures—but is much less common among Japanese and African diabetics. In the West, the presence of lesser, ‘subdiabetic’ degrees of glucose intolerance are probably independent ‘risk factors’ for accelerated atherosclerosis. Although many explanations for the link have been advanced—among them direct effects of glucose and insulin on the arterial wall, less direct effects of circulating lipoproteins, abnormalities of blood clotting and fibrinolysis and elevated blood pressure, even the influence of antidiabetic treatment itself—none has been clearly established. Nevertheless there is scope and hope that appropriate measures may reduce the raised arterial disease risk in the diabetic.

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams M. E., Jarrett R. J., Keen H., Boyns D. R., Crossley J. N. Oral glucose tolerance and related factors in a normal population sample. II. Interrelationship of glycerides, cholesterol, and other factors with the glucose and insulin response. Br Med J. 1969 Mar 8;1(5644):599–602. doi: 10.1136/bmj.1.5644.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chakrabarti R., Fearnley G. R. Pharmacological fibrinolysis in diabetes mellitus. Diabetologia. 1974 Feb;10(1):19–22. doi: 10.1007/BF00421409. [DOI] [PubMed] [Google Scholar]
  3. Davidson P. C., Albrink M. J. Insulin resistance in hyperglyceridemia. Metabolism. 1965 Oct;14(10):1059–1070. doi: 10.1016/0026-0495(65)90154-x. [DOI] [PubMed] [Google Scholar]
  4. Epstein F. H. Glucose intolerance and cardiovascular disease. Triangle. 1973;12(1):3–8. [PubMed] [Google Scholar]
  5. FEARNLEY G. R., CHAKRABARTI R., AVIS P. R. Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity. Br Med J. 1963 Apr 6;1(5335):921–923. doi: 10.1136/bmj.1.5335.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Garcia M. J., McNamara P. M., Gordon T., Kannel W. B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974 Feb;23(2):105–111. doi: 10.2337/diab.23.2.105. [DOI] [PubMed] [Google Scholar]
  7. Gibson T., Fuller J. H., Grainger S. L., Jarrett R. J., Keen H. Intralipid triglyceride and oral glucose tolerance. Diabetologia. 1974 Apr;10(2):97–100. doi: 10.1007/BF01219663. [DOI] [PubMed] [Google Scholar]
  8. Goto Y., Sato S. I., Masuda M. Causes of death in 3151 diabetic autopsy cases. Tohoku J Exp Med. 1974 Apr;112(4):339–353. doi: 10.1620/tjem.112.339. [DOI] [PubMed] [Google Scholar]
  9. Keen H. Factors influencing the progress of atherosclerosis in the diabetic. Acta Diabetol Lat. 1971 Sep;8 (Suppl 1):444–462. [PubMed] [Google Scholar]
  10. Keen H., Rose G., Pyke D. A., Boyns D., Chlouverakis C. Blood-sugar and arterial disease. Lancet. 1965 Sep 11;2(7411):505–508. doi: 10.1016/s0140-6736(65)91470-4. [DOI] [PubMed] [Google Scholar]
  11. Keen H., Track N. S., Sowry G. S. Arterial pressure in clinically apparent diabetics. Diabete Metab. 1975 Sep;1(3):159–178. [PubMed] [Google Scholar]
  12. Marigo S., Adezati L., Burnetti P., Pozza G., Robba L., Urbinati G. Misunderstanding or error? The UGDP report after four years. Acta Diabetol Lat. 1974 Sep-Oct;11(5):357–422. doi: 10.1007/BF02624579. [DOI] [PubMed] [Google Scholar]
  13. O'Malley C. B., Ward J. D., Timperley W. R., Porter N. R., Preston F. E. Platelet abnormalities in diabetic peripheral neuropathy. Lancet. 1975 Dec 27;2(7948):1274–1276. doi: 10.1016/s0140-6736(75)90610-8. [DOI] [PubMed] [Google Scholar]
  14. Pell S., D'Alonzo C. A. Factors associated with long-term survival of diabetics. JAMA. 1970 Dec 7;214(10):1833–1840. [PubMed] [Google Scholar]
  15. Reaven G. M., Lerner R. L., Stern M. P., Farquhar J. W. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest. 1967 Nov;46(11):1756–1767. doi: 10.1172/JCI105666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ross R., Glomset J. A. Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science. 1973 Jun 29;180(4093):1332–1339. doi: 10.1126/science.180.4093.1332. [DOI] [PubMed] [Google Scholar]
  17. Schonfeld G., Birge C., Miller J. P., Kessler G., Santiago J. Apolipoprotein B levels and altered lipoprotein composition in diabetes. Diabetes. 1974 Oct;23(10):827–834. doi: 10.2337/diab.23.10.827. [DOI] [PubMed] [Google Scholar]
  18. Soler N. G., Bennett M. A., Pentecost B. L., Fitzgerald M. G., Malins J. M. Myocardial infarction in diabetics. Q J Med. 1975 Jan;44(173):125–132. [PubMed] [Google Scholar]
  19. Stout R. W., Bierman E. L., Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res. 1975 Feb;36(2):319–327. doi: 10.1161/01.res.36.2.319. [DOI] [PubMed] [Google Scholar]
  20. Stout R. W. The effect of insulin on the incorporation of sodium (1- 14 C)-acetate into the lipids of the rat aorta. Diabetologia. 1971 Oct;7(5):367–372. doi: 10.1007/BF01219472. [DOI] [PubMed] [Google Scholar]
  21. Stout R. W., Vallance-Owen J. Insulin and atheroma. Lancet. 1969 May 31;1(7605):1078–1080. doi: 10.1016/s0140-6736(69)91711-5. [DOI] [PubMed] [Google Scholar]
  22. Tzagournis M., Chiles R., Ryan J. M., Skillman T. G. Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients with coronary heart disease. Circulation. 1968 Dec;38(6):1156–1163. doi: 10.1161/01.cir.38.6.1156. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES